179 related articles for article (PubMed ID: 11269735)
1. Pharmacokinetics, distribution, metabolism and excretion of.
Yasoshima K; Kuwabara T; Fuse E; Kuramitu T; Kurata N; Nishiie H; Oishi T; Kobayashi H; Kobayashi S
Cancer Chemother Pharmacol; 2001; 47(2):106-12. PubMed ID: 11269735
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of a novel protein kinase inhibitor, UCN-01.
Kurata N; Kuwabara T; Tanii H; Fuse E; Akiyama T; Akinaga S; Kobayashi H; Yamaguchi K; Kobayashi S
Cancer Chemother Pharmacol; 1999; 44(1):12-8. PubMed ID: 10367744
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
4. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
[TBL] [Abstract][Full Text] [Related]
7. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
8. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat.
Stüben J; Port R; Bertram B; Bollow U; Hull WE; Schaper M; Pohl J; Wiessler M
Cancer Chemother Pharmacol; 1996; 38(4):355-65. PubMed ID: 8674159
[TBL] [Abstract][Full Text] [Related]
10. Tissue distribution and plasma pharmacokinetics of UCN-01 at steady-state and following bolus administration in rats: influence of human alpha1-acid glycoprotein binding.
Hedaya MA; Daoud SS
Anticancer Res; 2001; 21(6A):4005-10. PubMed ID: 11911284
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, tissue distribution, and excretion of sitafloxacin, a new fluoroquinolone antibiotic, in rats, dogs, and monkeys.
Tachibana M; Tanaka M; Mitsugi K; Jin Y; Takaichi M; Okazaki O
Arzneimittelforschung; 2004; 54(12):898-905. PubMed ID: 15646375
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and disposition of the DOT1L inhibitor, pinometostat (EPZ-5676), in rat, dog and human.
Waters NJ; Smith SA; Olhava EJ; Duncan KW; Burton RD; O'Neill J; Rodrigue ME; Pollock RM; Moyer MP; Chesworth R
Cancer Chemother Pharmacol; 2016 Jan; 77(1):43-62. PubMed ID: 26645404
[TBL] [Abstract][Full Text] [Related]
13. Altered pharmacokinetics of a novel anticancer drug, UCN-01, caused by specific high affinity binding to alpha1-acid glycoprotein in humans.
Fuse E; Tanii H; Takai K; Asanome K; Kurata N; Kobayashi H; Kuwabara T; Kobayashi S; Sugiyama Y
Cancer Res; 1999 Mar; 59(5):1054-60. PubMed ID: 10070963
[TBL] [Abstract][Full Text] [Related]
14. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
15. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
Mukai H; Sugimoto T; Ago M; Morino A
Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.
Ahr HJ; Boberg M; Brendel E; Krause HP; Steinke W
Arzneimittelforschung; 1997 Jun; 47(6):734-45. PubMed ID: 9239452
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of UCN-01 in isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides.
Hagenauer B; Maier-Salamon A; Thalhammer T; Zöllner P; Senderowicz A; Jäger W
Oncol Rep; 2004 May; 11(5):1069-75. PubMed ID: 15069549
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of [125I]-recombinant human interleukin-11: 1. Absorption, distribution and excretion after subcutaneous administration to male rats.
Uchida T; Aoyama K; Mori K; Usui T; Watanabe T; Takariki Y; Asahara N; Hirose M; Kimura T; Tateishi M; Higuchi S
Eur J Drug Metab Pharmacokinet; 1998; 23(3):403-10. PubMed ID: 9842984
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 1st communication: plasma concentrations and excretions after a single intravenous 14C-NS-7 injection to rats, dogs and monkeys.
Nonaka K; Tsujioka T; Tougou K; Mukai H
Arzneimittelforschung; 2003; 53(9):612-20. PubMed ID: 14558434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
